SAFETY DATA SHEET Engemycin® Page 1 of 5 Section 1: Identification of the Substance and Supplier
Product name Engemycin Liquid containing 8-23% oxytetracycline hydrochloride Recommended use
Veterinary broad-spectrum antibiotic injection for use in horses, cattle, sheep, pigs, dogs and cats.
Company details MSD Animal Health, 33 Whakatiki Street, Upper Hutt Phone: 0800 800 543 Fax: 0800 808 100 Website: www.msd-animal-health.co.nz Hours: 8 am – 5 pm, Mon – Fri
Emergency telephone 0800 764 766 (0800 POISON) 24 hours human health 0800 243 622 (0800 CHEMCALL) 24 hours
Date of preparation Section 2: Hazards Identification Ecotoxic
6.4A May cause eye irritation 6.5B May cause an allergic skin reaction 6.8B Suspected of damaging fertility or the unborn child from repeated oral exposure 6.9B May cause damage to the gastrointestinal tract through prolonged or repeated inhalation or dermal exposure at high doses. 9.1B Toxic to aquatic organisms with long lasting effects
R63 Possible risk of harm to the unborn child R51 Toxic to aquatic organisms
Section 3: Composition/Information on Ingredients
Chemical name CAS number Concentration Section 4: First Aid Measures
Necessary first aid ACCIDENTAL SELF-INJECTION Wash and disinfect self injection injuries. measures
Seek medical advice if irritancy or an allergic response occurs – show this SDS. SKIN CONTACT In case of skin contact, while wearing protective gloves, carefully remove any contaminated clothing, including shoes, and wash skin thoroughly with soap and water. If irritation or symptoms occur or persist, consult a doctor. EYE CONTACT In case of eye contact, immediately rinse eyes thoroughly with SAFETY DATA SHEET Engemycin® Page 2 of 5
plenty of water. If wearing contact lenses, remove only after initial rinse, and continue rinsing eyes for at least 15 minutes. If irritation occurs or persists, consult a doctor. INGESTION Rinse mouth and drink a glass of water. Do not induce vomiting unless under the direction of a qualified medical professional or National Poisons Centre. If symptoms persist, consult a doctor. INHALATION Remove to fresh air and provide oxygen if necessary. If any trouble breathing, get immediate medical attention. Administer artificial respiration if breathing has ceased. If irritation or symptoms occur or persist, consult a doctor. Required instructions
For advice contact the National Poisons Centre 0800 POISON (0800 764 766)
Notes for medical
Accidental self-injection: Treat symptomatically. Some risk of hypersensitivity
personnel
from injection. Contamination of the needle must be considered.
Treat symptomatically any allergic reaction to tetracycline or any local irritancy caused by ethanolamine.
Workplace facilities
Emergency showers and eyewashes may be warranted depending on quantity and type of use.
Section 5: Fire Fighting Measures
Type of hazard Fire hazard properties Regulatory requirements Extinguishing media
Carbon dioxide (CO2), extinguishing powder or water spray
and methods Hazchem code Recommended protective
Wear full protective clothing and self-contained breathing apparatus (SCBA).
clothing Section 6: Accidental Release Measures
Emergency procedures
Wear chemical resistant gloves and overalls, facemask or goggles. Prevent further spillage. Adsorb spilled product and place in sealable container for disposal. Wash down affected area with water plus detergent. Absorb and collect washings and place in the same sealable container for disposal. Seek advice from the local authority regarding disposal. Avoid contamination of any water source or soil with product or empty container.
SAFETY DATA SHEET Engemycin® Page 3 of 5 Section 7: Handling and Storage
Precautions for safe
Avoid contact with skin, eyes, and mucosa. Keep containers adequately sealed
handling
during material transfer, transport, or when not in use. See Section 8 (Exposure
Regulatory requirements
Signage required where quantities greater than 1000L are present. Emergency Plan required where quantities greater than 1000L are present.
Handling practices
Avoid contact with skin. Keep containers adequately sealed during material transfer, transport, or when not in use.
Approved handlers Conditions for safe
Store in original container in a cool, dry, ventilated place away from direct heat or
direct sunlight. Keep container sealed when not in use. Keep out of reach of
Store site requirements
Store protected from light at room temperature (8-30°C). Do not refrigerate or freeze.
Packaging Section 8: Exposure Control/Personal Protection
Workplace exposure
Ethanolamine TWA 3.0ppm (7.5mg/m3) (OSH NZ)
standards Application in the
Ensure adequate ventilation. Keep container sealed when not in use.
workplace Exposure standards
No TEL is set for this substance at this time
outside the workplace
No EEL is set for this substance at this time
Personal protection
Wear chemical resistant gloves, facemask or goggles.
Section 9: Physical and Chemical Properties SAFETY DATA SHEET Engemycin® Page 4 of 5 Section 10: Stability and Reactivity
Stability of the substance Conditions to avoid Material to avoid Hazardous decomposition
May also evolve nitrogen oxides, sulphur oxides and carbon oxides when heated
products Section 11: Toxicological Information Acute effects for individual ingredients only
Ethanolamine LD50: 620mg/kg (guinea pig)
Oxytetracycline Hydrochloride LD50: 6696 mg/kg (mouse) Sodium Formaldehyde Sulphoxylate LD50 4000mg/kg (mouse)
No TEL is set for this substance at this time.
Chronic/long term effects for individual ingredients only Section 12: Environmental Information Effects for individual ingredients only.
Oxytetracycline Hydrochloride: 0.207mg/L EC50 96hr (Microcystis aeruginosa)
No EEL is set for this substance at this time.
Section 13: Disposal Considerations Disposal information Disposal
Dispose of unused contents in a suitable landfill. Avoid contamination of any water
source or the environment with product or empty container.
Container Disposal
Dispose of empty container by puncturing and burying in a suitable landfill.
Reference
Current version of NZS 8409 Management of Agrichemicals
Section 14: Transport Information Relevant information
UN3082 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (oxytetracycline hydrochloride) Marine Pollutant Class 9 PG III Limited quantities: 5L Maximum quantity for own agricultural use: 1000L
Other requirements SAFETY DATA SHEET Engemycin® Page 5 of 5 Section 15: Regulatory Information Regulatory status
HSNO Approval Code: HSR002217. For a full listing of controls see www.epa.govt.nz ACVM registration number: A003308. For conditions of registration see www.foodsafety.govt.nz RESTRICTED VETERINARY MEDICINE
HSNO and ACVM Signage: 1000 Litres controls Emergency Plan: 1000 Litres Section 16: Other Information Additional information
Schering-Plough Animal Health Ltd known as MSD Animal Health, is a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Schering-Plough urges each user or recipient of this SDS to read the entire data sheet to become aware of the potential hazards associated with this material. This SDS summarises, at the date of issue, our best knowledge of the health and safety hazard information. Although reasonable care has been taken in the preparation of this document, Intervet Limited extend no warranties and make no representations as to the accuracy or completeness of the information contained therein, and assume no responsibility regarding the suitability of this information for the user's intended purposes or for the consequence of its use. Each individual should make a determination as to the suitability of the information for their particular purpose(s).
Detail-Document #200509 −This Detail-Document accompanies the related article published in− PHARMACIST’S LETTER / PRESCRIBER’S LETTER Drug-Induced Photosensitivity Lead author: Kelly M. Shields, Pharm.D. Drugs Reported to Cause Photosensitivity Reactions 1-11 Therapeutic Class Comments ( Zyrtec ), cyproheptadine ( Periactin ), diphenhydramine ( Benadryl ),
R E D U C I N G S E R U M I N S U L I N A N D OVA R I A N CY TO C H RO M E P 4 5 0 c 1 7 a I N P O LYCYST I C OVA RY SY N D RO M E DECREASES IN OVARIAN CYTOCHROME P450c17 a ACTIVITY AND SERUM FREE TESTOSTERONE AFTER REDUCTION OF INSULIN SECRETION IN POLYCYSTIC